SCHEMBL7052347

SCHEMBL7052347

C#Cc1cc(-c2ccccc2)ccc1C(=O)Nc1ccccc1S(=O)(=O)NC(=O)C(C)(C)C

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.40
ACLY P53396 5/20 0.37
PLA2G7 Q13093 1/20 0.36
MEN1 O00255 3/20 0.36
KMT2A Q03164 3/20 0.36
RAB9A P51151 1/20 0.36
ALDH1A1 P00352 3/20 0.35
KDM4E B2RXH2 2/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
POLB P06746 1/20 0.35
GAA P10253 1/20 0.35
HPGD P15428 1/20 0.35
DHODH Q02127 1/20 0.34
SMO Q99835 1/20 0.34
MCL1 Q07820 1/20 0.34
FLT1 P17948 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7049830 0.90 HDAC1 (0.38) HDAC1ACLYPLA2G7MEN1KMT2A
SCHEMBL7052305 0.85 HDAC8 (0.35) HDAC1ACLYPLA2G7MEN1KMT2A
SCHEMBL7076345 0.84 ACLY (0.46) ACLYMCL1
SCHEMBL7050676 0.83 HDAC8 (0.34) HDAC1ACLYPLA2G7MEN1KMT2A
SCHEMBL7048488 0.83 SOAT1 (0.41) HDAC1KDM4EPOLB
SCHEMBL7051023 0.82 SOAT1 (0.43) HDAC1HDAC6POLB
SCHEMBL7049821 0.82 HDAC1 (0.34) HDAC1ACLYPLA2G7
SCHEMBL7080297 0.80 KMT2A (0.46) MEN1KMT2AALDH1A1LMNAMAPT
SCHEMBL7076566 0.77 BCL2L1 (0.55) HDAC1ALDH1A1HDAC8HDAC6GAA
SCHEMBL7047776 0.71 CA1 (0.51) KMT2ARAB9AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030191323-A1 Hypoglycemic agent AJINOMOTO CO., INC. (JP) 2003-10-09 US disclosed
US-20030162818-A1 Acylsulfonamide derivative AJINOMOTO CO. INC. (JP) 2003-08-28 US disclosed
US-6555584-B1 Acetyl-coa carboxylase inhibitors AJINOMOTO CO., INC. (JP) 2003-04-29 US disclosed
EP-1300142-A1 HYPOGLYCEMICS Ajinomoto Co., Inc. (JP) 2003-04-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030162818-A1 Acylsulfonamide derivative ACSS2, ACACA, FASN HDAC1 271/4885ACLY 181/4885PLA2G7 363/4885
US-20030191323-A1 Hypoglycemic agent GPR119, IAPP, SLC5A2 HDAC1 305/4885ACLY 41/4885PLA2G7 263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.